Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 16.


Selby, P, Liu, L, Downing, A et al. (10 more authors) (2019) How can clinical research improve European health outcomes in cancer? Journal of Cancer Policy, 20. ARTN 100182. ISSN 2213-5383

Wilson, R (2019) ‘Our late most excellent viceroy’: Irish Responses to the Death of the Duke of Rutland in 1787. Journal for Eighteenth-Century Studies, 42 (1). pp. 67-83. ISSN 1754-0194

Clarke, EL, Revie, C, Brettle, D et al. (6 more authors) (2018) Development of a novel tissue-mimicking color calibration slide for digital microscopy. Color Research and Application, 43 (2). pp. 184-197. ISSN 0361-2317

Adams, R, Brown, E, Brown, L et al. (14 more authors) (2018) Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial. Lancet Gastroenterology and Hepatology, 3 (3). pp. 162-171. ISSN 2468-1253

Shoemark, A, Moya, E, Hirst, RA et al. (34 more authors) (2018) High prevalence of CCDC103 p.His154Pro mutation causing primary ciliary dyskinesia disrupts protein oligomerisation and is associated with normal diagnostic investigations. Thorax, 73 (2). pp. 157-166. ISSN 0040-6376

Bierma-Zeinstra, SMA, Brew, J, Stoner, K et al. (3 more authors) (2017) A New Lipid Formulation Of Low Dose Ibuprofen Shows Non-Inferiority To High Dose Standard Ibuprofen: The Flare Study (Flaring Arthralgia Relief Evaluation In Episodic Flaring Knee Pain) - A Randomised Double-Blind Study. Osteoarthritis and Cartilage, 25 (12). pp. 1942-1951. ISSN 1063-4584

Beeken, RJ, Croker, H, Heinrich, M et al. (10 more authors) (2017) The Impact of Diet-Induced Weight Loss on Biomarkers for Colorectal Cancer: An Exploratory Study (INTERCEPT). Obesity, 25 (S2). S95-S101. ISSN 1930-7381

Ridings-Figueroa, R, Stewart, ER, Nesterova, TB et al. (14 more authors) (2017) The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes and Development, 31 (9). pp. 876-888. ISSN 0890-9369

Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836

Beeken, RJ, Leurent, B, Vickerstaff, V et al. (6 more authors) (2017) A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial. International Journal of Obesity, 41 (2). pp. 246-254. ISSN 0307-0565

Lawler, M, Banks, I, Law, K et al. (57 more authors) (2017) The European Cancer Patient’s Bill of Rights, update and implementation 2016. ESMO Open, 2016 (1). e000127. ISSN 2059-7029

Bogaerts, J, Sydes, MR, Keat, N et al. (43 more authors) (2014) Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. European journal of cancer. ISSN 0014-2964

Wilson, R, Goodacre, SW, Klingbajl, M et al. (6 more authors) (2013) Evaluation of the DAVROS (Development And Validation of Risk-adjusted Outcomes for Systems of emergency care) risk-adjustment model as a quality indicator for healthcare. Emergency Medicine Journal. ISSN 1472-0205

Owens, OJ, Taggart, C, Wilson, R et al. (3 more authors) (1993) Interleukin-2 receptor and ovarian cancer. British Journal of Cancer, 68 (2). pp. 364-367. ISSN 1532-1827

Proceedings Paper

Richman, SD, Adams, R, Brown, E et al. (14 more authors) (2017) FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, bRAF and PIK3CA. In: Journal of Pathology. Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 Jun 2017, Belfast, Northern Ireland, UK. Wiley , S13-S13.

Adams, RA, Brown, E, Brown, L et al. (13 more authors) (2016) FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS & NRAS. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen. Oxford University Publishing .

This list was generated on Mon Oct 14 04:54:29 2019 BST.